Sibel Ozyazgan, Nilüfer Kutluata, Selim Afşar, Sule Beyhan Ozdaş, Ahmet Gökhan Akkan
文献索引:Pharmacology 74(3) , 119-26, (2005)
全文:HTML全文
We investigated the vascular effects of glucagon-like peptide-1 (GLP-1) and Exendin-4 in type 2 diabetic rat aortae. Studies were performed in a normal control group (NC) (0.2 ml i.p. saline, n = 10), streptozotocin (STZ)/nicotinamide diabetic control group (DC) (a single dose of 80 mg/kg STZ i.p. injection 15 min after administration of 230 mg/kg nicotinamide i.p.), GLP-1 (GLPC) control group (1 microg/kg twice daily i.p. for 1 month, n = 10), Exendin-4 control group (EXC) (0.1 microg/kg twice daily i.p. for 1 month, n = 10), GLP-1-treated diabetic group (GLPT) (1 microg/kg twice daily i.p. for 1 month, n = 10), and Exendin-4-treated diabetic group (EXT) (0.1 microg/kg twice daily i.p. for 1 month, n = 10). One month of GLP-1 and Exendin-4 treatment significantly decreased the blood glucose levels of diabetic rats (113 +/- 2 mg/dl, p < 0.001, and 117 +/- 1 mg/dl, p < 0.001, respectively versus 181 +/- 9 mg/dl in the DC group). Sensitivity (pD2) and maximum response (% Max. Relax) of acetylcholine-stimulated relaxations in the DC group (pD2: 6.73 +/- 0.12 and 55 +/- 6, respectively) were decreased compared with the non-diabetic NC group (pD2: 7.41 +/- 0.25, p < 0.05, and 87 +/- 4, p < 0.01). Treating diabetic rats with GLP-1, pD2 values and with Exendin-4, Max. Relax %values of aortic strips to acetylcholine returned to near non-diabetic NC values (pD2: 7.47 +/- 0.15, p < 0.05, and 87 +/- 3, p < 0.01, respectively). Maximal contractile responses (Emax) to noradrenaline in aortic strips from the diabetic DC group (341 +/- 27 mg tension/mg wet weight) were significantly decreased compared with the non-diabetic NC (540 +/- 66 mg tension/mg wet weight, p < 0.001) and the GLPT group (490 +/- 25 mg tension/mg wet weight, p < 0.05). There were no significant differences in pD2 values of aortic strips to noradrenaline from all groups. Emax to KCl in aortic strips from the DC group (247 +/- 10 mg tension/mg wet weight, p < 0.01) was significantly decreased compared with non-diabetic NC group (327 +/- 26 mg tension/mg wet weight). Treating diabetic rats with GLP-1 (GLPT), Emax values of aortic strips to KCl returned to near non-diabetic NC values (271 +/- 12 mg tension/mg wet weight). GLP-1 and (partially) Exendin-4 treatment could improve the increased blood glucose level and normalize the altered vascular tone in type 2 diabetic rats.2005 S. Karger AG, Basel
结构式 | 名称/CAS号 | 分子式 | 全部文献 |
---|---|---|---|
![]() |
胰高血糖素样肽1(7-36)酰胺(人,大鼠)
CAS:107444-51-9 |
C149H226N40O45 |
Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)a...
2004-02-01 [Metab. Clin. Exp. 53(2) , 252-9, (2004)] |
Coexpression of glucagon-like peptide-1 (GLP-1) receptor, va...
1999-01-01 [J. Neurochem. 72(1) , 10-6, (1999)] |
Elevated post-prandial gastric inhibitory polypeptide concen...
1997-10-01 [Clin. Sci. 93(4) , 343-7, (1997)] |
Simultaneous determination of incretin hormones and their tr...
2004-04-15 [J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 803(1) , 91-9, (2004)] |
Intracerebroventricular glucagon-like peptide-1 (7-36) amide...
1998-06-01 [Physiol. Behav. 64(3) , 367-72, (1998)] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved